Femara (Letrozole)
Femara is used to treat postmenopausal women with breast cancer that is resistant to the more commonly-used anti-estrogen medications such as tamoxifen (Nolvadex). It also is approved for treating postmenopausal women after surgery who have hormone-sensitive early breast cancer.
Take by mouth once daily with or without food or as directed. Do not stop taking this medication unless instructed to do so by your doctor or pharmacist. Continue to take your other medications unless instructed otherwise.
Femara is an oral, anti-estrogen drug that is used for treating postmenopausal women with breast cancer. The growth of some breast cancers in postmenopausal women is promoted by estrogens that circulate in the blood, and the adrenal glands are the main source of these circulating estrogens. Femara inhibits the enzyme in the adrenal glands (aromatase) that produces the estrogens, estradiol and estrone. Femara was approved by the FDA in 1997.
If you miss a dose of Mentax, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Store at room temperature between 59 and 86 degrees F (15-30 degrees C) away from light and moisture.
